AS

Arlene H. Sharpe

DI Dana-Farber Cancer Institute: 4 patents #4 of 242Top 2%
Harvard University: 4 patents #11 of 527Top 3%
EU Emory University: 1 patents #14 of 126Top 15%
NA Novartis Ag: 1 patents #62 of 478Top 15%
BH Brigham and Women's Hospital: 1 patents #37 of 199Top 20%
BC Beth Israel Deaconess Medical Center: 1 patents #13 of 79Top 20%
UP University of Pennsylvania: 1 patents #50 of 270Top 20%
CC Children'S Medical Center: 1 patents #24 of 170Top 15%
📍 Brookline, MA: #31 of 502 inventorsTop 7%
🗺 Massachusetts: #752 of 13,863 inventorsTop 6%
Overall (2022): #52,891 of 548,613Top 10%
4
Patents 2022

Issued Patents 2022

Showing 1–4 of 4 patents

Patent #TitleCo-InventorsDate
11492403 Anti-phosphotyrosinylated programmed death 1 (PD-1) monoclonal antibodies, methods of making and methods of using thereof Gordon J. Freeman, Vassiliki Boussiotis, Xia Bu, Vikram Juneja, Nikolaos Patsoukis +2 more 2022-11-08
11413340 Mesothelin chimeric antigen receptor (CAR) and antibody against PD-L1 inhibitor for combined use in anticancer therapy Jennifer Brogdon, Hwai Wen Chang, Boris Engels, Gordon J. Freeman, Gerhard Frey +2 more 2022-08-16
11359013 Methods and compositions for the treatment of persistent infections and cancer by inhibiting the programmed cell death 1 (PD-1) pathway Gordon J. Freeman, David M. Dorfman, Rafi Ahmed, Daniel Barber, E. John Wherry 2022-06-14
11359020 Agents that modulate immune cell activation and methods of use thereof Gordon J. Freeman, Yanping Xiao, Loise M. Francisco, Rosemarie Dekruyff, Dale T. Umetsu 2022-06-14